Case report: Successful treatment of refractory membranous nephropathy with telitacicept
Despite various treatment methods, the remission rate of membranous nephropathy remains limited. Refractory membranous nephropathy especially lacks effective treatment plans. Telitacicept achieves comprehensive inhibition of CD20-positive B cells, plasma cells, and T cells, thereby bringing new hope...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268929/full |
_version_ | 1827792610194882560 |
---|---|
author | Lei Zhang Hua Jin Dong Wang Yiping Wang |
author_facet | Lei Zhang Hua Jin Dong Wang Yiping Wang |
author_sort | Lei Zhang |
collection | DOAJ |
description | Despite various treatment methods, the remission rate of membranous nephropathy remains limited. Refractory membranous nephropathy especially lacks effective treatment plans. Telitacicept achieves comprehensive inhibition of CD20-positive B cells, plasma cells, and T cells, thereby bringing new hope to the treatment of membranous nephropathy and refractory membranous nephropathy. Here, we report a case of a 46-year-old man with membranous nephropathy. Although the combined treatment with glucocorticoid, tacrolimus, mycophenolate mofetil, cyclophosphamide, and rituximab was not successful, the patient achieved complete remission of urinary protein after glucocorticoid combined with telitacicept. This is the first report on the application of telitacicept in the treatment of membranous nephropathy, especially refractory membranous nephropathy. The application of telitacicept in the treatment of membranous nephropathy deserves further attention. |
first_indexed | 2024-03-11T18:05:32Z |
format | Article |
id | doaj.art-d477528ebca94e4da1b5387c01aa5e21 |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-03-11T18:05:32Z |
publishDate | 2023-10-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-d477528ebca94e4da1b5387c01aa5e212023-10-17T07:41:36ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-10-011410.3389/fimmu.2023.12689291268929Case report: Successful treatment of refractory membranous nephropathy with telitaciceptLei ZhangHua JinDong WangYiping WangDespite various treatment methods, the remission rate of membranous nephropathy remains limited. Refractory membranous nephropathy especially lacks effective treatment plans. Telitacicept achieves comprehensive inhibition of CD20-positive B cells, plasma cells, and T cells, thereby bringing new hope to the treatment of membranous nephropathy and refractory membranous nephropathy. Here, we report a case of a 46-year-old man with membranous nephropathy. Although the combined treatment with glucocorticoid, tacrolimus, mycophenolate mofetil, cyclophosphamide, and rituximab was not successful, the patient achieved complete remission of urinary protein after glucocorticoid combined with telitacicept. This is the first report on the application of telitacicept in the treatment of membranous nephropathy, especially refractory membranous nephropathy. The application of telitacicept in the treatment of membranous nephropathy deserves further attention.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268929/fullcase reportsuccessfultreatmentrefractory membranous nephropathytelitacicept |
spellingShingle | Lei Zhang Hua Jin Dong Wang Yiping Wang Case report: Successful treatment of refractory membranous nephropathy with telitacicept Frontiers in Immunology case report successful treatment refractory membranous nephropathy telitacicept |
title | Case report: Successful treatment of refractory membranous nephropathy with telitacicept |
title_full | Case report: Successful treatment of refractory membranous nephropathy with telitacicept |
title_fullStr | Case report: Successful treatment of refractory membranous nephropathy with telitacicept |
title_full_unstemmed | Case report: Successful treatment of refractory membranous nephropathy with telitacicept |
title_short | Case report: Successful treatment of refractory membranous nephropathy with telitacicept |
title_sort | case report successful treatment of refractory membranous nephropathy with telitacicept |
topic | case report successful treatment refractory membranous nephropathy telitacicept |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268929/full |
work_keys_str_mv | AT leizhang casereportsuccessfultreatmentofrefractorymembranousnephropathywithtelitacicept AT huajin casereportsuccessfultreatmentofrefractorymembranousnephropathywithtelitacicept AT dongwang casereportsuccessfultreatmentofrefractorymembranousnephropathywithtelitacicept AT yipingwang casereportsuccessfultreatmentofrefractorymembranousnephropathywithtelitacicept |